- Home
- SHMD vs HLVX Comparison
SHMD vs HLVX Comparison
Compare SHMD & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHMD
- HLVX
- Stock Information
- Founded
- SHMD 1864
- HLVX 2020
- Country
- SHMD Germany
- HLVX United States
- Employees
- SHMD N/A
- HLVX N/A
- Industry
- SHMD
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- SHMD
- HLVX Health Care
- Exchange
- SHMD Nasdaq
- HLVX Nasdaq
- Market Cap
- SHMD 100.8M
- HLVX 92.6M
- IPO Year
- SHMD N/A
- HLVX 2022
- Fundamental
- Price
- SHMD $3.25
- HLVX $1.86
- Analyst Decision
- SHMD
- HLVX Hold
- Analyst Count
- SHMD 0
- HLVX 5
- Target Price
- SHMD N/A
- HLVX $2.33
- AVG Volume (30 Days)
- SHMD 58.0K
- HLVX 317.3K
- Earning Date
- SHMD 12-31-2024
- HLVX 11-07-2024
- Dividend Yield
- SHMD N/A
- HLVX N/A
- EPS Growth
- SHMD 1309.32
- HLVX N/A
- EPS
- SHMD 1.07
- HLVX N/A
- Revenue
- SHMD $99,752,404.00
- HLVX N/A
- Revenue This Year
- SHMD N/A
- HLVX N/A
- Revenue Next Year
- SHMD N/A
- HLVX N/A
- P/E Ratio
- SHMD $3.09
- HLVX N/A
- Revenue Growth
- SHMD N/A
- HLVX N/A
- 52 Week Low
- SHMD $1.98
- HLVX $1.55
- 52 Week High
- SHMD $6.13
- HLVX $20.22
- Technical
- Relative Strength Index (RSI)
- SHMD N/A
- HLVX 44.78
- Support Level
- SHMD N/A
- HLVX $1.95
- Resistance Level
- SHMD N/A
- HLVX $1.97
- Average True Range (ATR)
- SHMD 0.00
- HLVX 0.07
- MACD
- SHMD 0.00
- HLVX -0.02
- Stochastic Oscillator
- SHMD 0.00
- HLVX 10.00
About SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.